PNAS Publication Of AIDS Article Spurs Debate Over Peer Review

Some members of the National Academy of Sciences no doubt were shocked this past February when the latest edition of their thick, pale gray journal—Proceedings of the NAS— arrived in their mailboxes. Here was the National Academy—the most respected, and surely the most cautions, scientific body in the United States—publishing in its very own “house organ” the work of Peter Duesberg, the respected but controversial University of California, Berkeley, retrov

Written byAnthony Liversidege
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Some members of the National Academy of Sciences no doubt were shocked this past February when the latest edition of their thick, pale gray journal—Proceedings of the NAS— arrived in their mailboxes. Here was the National Academy—the most respected, and surely the most cautions, scientific body in the United States—publishing in its very own “house organ” the work of Peter Duesberg, the respected but controversial University of California, Berkeley, retrovirologist who has been arguing for two years now that HIV is in no way the cause of AIDS. This opinion has earned Duesberg little more than opprobrium throughout the AIDS research community, since his ideas are totally at odds with the consensus view in the biomedical field. And yet, there he was, in PNAS [volume 86(3), pages 755-764], not only raising the same heretical notions all over again, but doing so at greater length than ever and with 196 references.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies